| Indication | Product | Partner | Status |
|---|
| Neutropenia | Neulasta®
(pegfilgrastim) | Amgen | FDA Approved |
| Hepatitis C | PEGASYS®
(peginterferon alfa-2a) | Roche | FDA Approved |
| Hepatitis C | PEG-INTRON®
(peginterferon alfa-2b) | Schering-Plough | FDA Approved |
| Macular Degeneration | Macugen®
(pegaptanib sodium) | (OSI)-Eyetech | FDA Approved
Filed in EU |
| Renal Anemia | Mircera™
(continuous erythropoiesis receptor activator) | Roche | Approved in EU
Filed in U.S. |
| Crohn's Disease | Cimzia
(peg-anti-TNF alpha
antibody fragment) | UCB Pharma | Approved in U.S.
Approved/Launched
In Switzerland |
| Rheumatoid Arthritis | Cimzia
(peg-anti-TNF alpha
antibody fragment) | UCB Pharma | Filed in U.S. |
| Acromegaly | Somavert®
(pegvisomant) | Pfizer | FDA Approved |
| Cardiac Imaging | DEFINITY® Vial
(perflutren lipid microsphere injectable suspension) | Bristol-Myers Squibb | FDA Approved |
| Cranial Dural Sealant | DuraSeal®
Dural Sealant... | Confluent Surgical | FDA Approved |
Home 
Pipeline Overview 
